Tag Archives: medical device

Hot Investor Mandate 1: Newly Founded Family Office Actively Seeking Early-Stage Life Science Investments, from Pre-Clinical Stage Assets to Medical Devices

15 Mar

A newly formed Delaware family office investment vehicle representing East Coast-based family interests is looking to invest in ground-breaking life science and medical device technologies. While the firm is very flexible in terms of investment size, they are generally looking to invest a minimum of $0.5 million per round. The firm is open to Investing in companies located throughout North America and Europe.

The firm is looking for breakthrough technologies with a strong social ethos in the Therapeutics, Medical Device and Diagnostics Sectors that address underserved medical needs, or provide innovative and disruptive approaches to common medical procedures and treatments. The firm invests on an opportunistic basis and are especially interested in areas of intersecting technologies, such as nucleic acid-based drugs and delivery, regenerative medicine and cell- based therapeutics.

The firm is less interested in small molecules and generally will not consider biosimilars or other technologies for which there is already multiple therapeutic options. The firm is looking for niche disease areas where disruptive therapeutics have the potential to be truly disease- modifying, not just provide symptomatic relief or palliative care. The firm typically is interested in preclinical stage assets that have well-developed animal model dossiers to Phase II or early Phase III stage assets. The firm’s investment mandate particularly focuses on “smart” clinical trial formats such as adaptive trials and Master Protocol trials for capital efficiency.

For devices, the firm is looking for devices that address and perhaps substitute for a pharmacologic in a given therapeutic market, such as deep brain stimulation technologies and orthopedics. The firm is generally not interested in cardiovascular disease or diabetes.

The firm is currently reviewing co-investment opportunities in private companies and on an opportunistic basis, considering investment in micro-and small-cap public companies as a direct investor.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Tags: , , , , , , , , , , , ,

RESI San Francisco @ JPM Week – Medical Devices Panel Announcement

14 Dec

By Claire Jeong, Research Analyst, LSN

claire

With RESI San Francisco less than a month away, we are proud to announce the Medical Device investors panel, where 5 seasoned experts in medical device investments will discuss how they seek to work with early-stage medical technology entrepreneurs.

The fundraising process and path to commercialization for medical device products continue to be a rigorous challenge for many budding companies. Especially with the exponential growth of the IoT/IoMT market, a growing number of entrepreneurs are focusing on the development of connected, “smarter” devices that incorporate a software or data component. Although often overshadowed by the biopharmaceutical industry in terms of degree of need or financial returns, the medical device sector is a very much needed area in the improvement of healthcare.

If you are a medical device entrepreneur and heading to San Francisco for JPM week, you do not want to miss out on our RESI Medical Devices panel! Our panelists are:

  • Renee Ryan, Vice President, JJDC, Johnson & Johnson Innovation (JLABS)
  • Yao Li Ho, Director of Business Development, LYFE Capital
  • Zishan “Z” Haroon, Chairman & General Partner, Julz Co LLC
  • Sam Ifergan, President & CEO, iGan Partners
  • Randy Scott, Partner, HealthQuest Capital

Tags: , , , , ,

Medical Device Investors Share Their Expert Advice at RESI San Diego

25 May

By Lucy Parkinson, Director of Research, LSN

The medical device industry is consolidating rapidly, and many entrepreneurs find the medtech fundraising landscape challenging to navigate.  However, there are a great diversity of early stage device investors out there looking for deals. This RESI panel brings together device investors from US and international VCs, a major device firm, and a private investment group to discuss how they assess medical device opportunities, and how an entrepreneur can build a productive dialogue with their firm.

Moderated by David Cassak (CEO, Innovation In Medtech), the panelists are:

Tags: , , , ,

RESI@TMCx Panel: Medical Device Investors Share Their Strategies

24 Mar

By Lucy Parkinson, Director of Research, LSN

Medtech innovation is one of the focuses of Texas Medical Center’s innovation programs, with TMCx focusing its startup acceleration program on medical devices and healthcare IT. RESI@TMCx will provide a venue for investors to meet with innovative medical device startups from Texas and beyond, and this panel session will explore what it takes to get a new device product funded and commercialized.

Moderated by Angela Shah, Editor, Xconomy, the panelists are:

The panelists will share their experience and insight on the medical device sector, including what areas of medical technology are of peak interest right now, what factors they examine when performing diligence on a medical device company, and what opportunities they see for the future of device innovation. If you’d like to hear from these experienced investors and from our expert moderator, you can register for RESI now.

Tags: , , , , , ,

RESI Panel Announcement: Medical Device Investors

12 Nov

By Lucy Parkinson, Senior Research Manager, LSN

Medical technology represents a major segment of life science investment, with $2.7 billion in venture allocations going into devices and diagnostics in 2014.  At LSN, we track over 700 investors who have an interest in development or clinical-stage medical devices.  For RESI San Francisco, LSN has gathered a panel of experienced medical device investors to share their expertise and advice with medtech entrepreneurs.

Moderated by David Cassak, Managing Partner, Innovation In Medtech, our panelists are:

The panel will explore the challenges of raising a financing round in the medical device sector, providing advice for entrepreneurs from early development stages through to commercialization.  These investors will explain what makes a device startup stand out, and how they assess the potential risks of a device opportunity.  If you’d like to join us at RESI, register now.

RESI-San-Francisco-2016

 

Tags: , , , ,

Hot Life Science Investor Mandate 2: Family Office Seeking 510k Devices in Eastern US

7 May

The operational and investment arm of a family office is looking to make equity investments into early stage companies and small mid-market growth companies ranging from $.5 to $1 million. The firm is very open to syndication particular with early stage deals and is capable of providing additional capital in follow on rounds when appropriate. The firm prefers to invest in companies located in the eastern United States and looks to make approximately 1-2 new investments per year.

The firm is looking for companies in the Medical Technology and Diagnostics space. Within these areas the firm is looking for 510k devices that are more technically based with a particular interest in hospital equipment and professional diagnostics. The firm is not interest in devices where the final consumer is the patient. The firm is looking to devices that improve the standard of care and is willing to invest in companies at all phases of development. The firm is generally open to all indications.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Tags: , ,

Hot Life Science Investor Mandate 1: Multi-Family Office Rapidly Making New Allocations

9 Jan

Allocation Information

A multi-family office based in the Western US is an active investor in the medical device sector, and is interested in opportunities worldwide.  Initial investments are typically about $50,000 with the potential for follow-on investments totaling $500,000, and may be structured as equity or as debt.  The office does not invest in seed rounds.  In the recent past the office has allocated new investments at a rate of approximately one per month.  The firm offers support and expertise to portfolio companies but does not seek a board seat.

Sectors & Subsectors of Interest

Within the medical device sector, only devices with a basis in mechanical engineering, such as electro-mechanical medical devices, active implantable devices such as pacemaker technologies, and surgical instruments are of interest.  The family office invests only in companies that have already developed a prototype of their product and filed a patent application; the firm prefers that companies that seek an allocation have in-human data but does not require this.

Company & Management Team Requirements

The family office seeks to invest in strong management teams with prior experience in the medical device industry, preferably with previous successful exits and with a strong reputation in their niche.  The firm invests only in privately-held companies and prefers to make investments with the potential to exit within 3-4 years.

Tags: , , , ,

← Older Entries
Newer Entries →